Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-Activity Relationships of Pyrrolyl-Containing Diketo Acid and Non-Diketo Acid Derivatives as Inhibitors of SARS-CoV-2 nsp13-Associated Activities.

Molecules (Basel, Switzerland)·2026
Same author

Twin engines of viral replication: Medicinal chemistry insights on SARS-CoV-2 nsp12 and nsp13.

European journal of medicinal chemistry·2026
Same author

<i>N</i>-alkyl and <i>N</i>-benzyl indoles are anti-SARS-CoV-2 agents and nsp13 inhibitors.

Journal of enzyme inhibition and medicinal chemistry·2025
Same author

Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment.

International journal of pharmaceutics·2025
Same author

Exploring structure-activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzyme.

Journal of enzyme inhibition and medicinal chemistry·2025
Same author

Structure-Activity Relationships of New 1-Aryl-1H-Indole Derivatives as SARS-CoV-2 Nsp13 Inhibitors.

ChemMedChem·2025

Related Experiment Video

Updated: May 25, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Will integrase inhibitors be used as microbicides?

Giuliana C Crucitti1, Maurizio Botta, Roberto Di Santo

  • 1Pasteur Institute, Fondazione Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, Facoltà di Farmacia e Medicina, Sapienza Università di Roma, I-00185 Roma, Italy.

Current HIV Research
|January 24, 2012
PubMed
Summary

New topical microbicides, specifically integrase inhibitors, show promise in preventing HIV-1 transmission. These compounds are being evaluated for pre- and post-exposure prophylaxis, offering a potential new strategy against sexually transmitted infections.

More Related Videos

Assembly and Purification of Prototype Foamy Virus Intasomes
10:20

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
10:34

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes

Published on: February 22, 2017

Related Experiment Videos

Last Updated: May 25, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Assembly and Purification of Prototype Foamy Virus Intasomes
10:20

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
10:34

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes

Published on: February 22, 2017

Area of Science:

  • Virology
  • Infectious Diseases
  • Drug Development

Background:

  • Developing an effective HIV-1 vaccine remains a significant challenge.
  • Microbicides are crucial for preventing sexually transmitted infections, including HIV-1.
  • Integrase inhibitors represent a novel class of potential HIV-1 microbicides.

Purpose of the Study:

  • To provide an overview of integrase inhibitors as potential topical microbicides.
  • To compare the efficacy of integrase inhibitors with existing HIV-specific and non-specific microbicides.
  • To evaluate integrase inhibitors for pre- and post-exposure prophylaxis against HIV-1.

Main Methods:

  • In vitro and ex vivo assays were used to test microbicide efficacy.
  • Candidate microbicides were assessed in models mimicking sexual transmission of HIV-1.
  • The naphthyridinecarboxyamide L-870,812 was specifically evaluated.

Main Results:

  • Few integrase inhibitors have demonstrated efficacy in blocking HIV-1 infection in relevant models.
  • L-870,812 showed comparable efficacy to the reverse transcriptase inhibitor PMPA in blocking viral infection.
  • Efficacy was observed in both pre-exposure and post-exposure prophylactic settings.

Conclusions:

  • Integrase inhibitors are a promising new class of topical microbicides for HIV-1 prevention.
  • L-870,812 is a notable candidate for further development.
  • Topical microbicides, including integrase inhibitors, offer a viable strategy in the absence of an HIV-1 vaccine.